FEEDOTCOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
ENvue Medical, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 17, 2026
$0.50+0.13 (+34.73%)
Close on Oct 19, 2026
- Market cap
- $3.08M
- P/E (TTM)
- –
- Dividend yield
- –
ENvue Medical, Inc. revenue by segment
By business segment
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nano Vibronix [Member] | $1.86M | $2.56M | – | – | – | – | – | – | – | – | 72.7% | -27.4% |
| ENvue [Member] | $696.00K | – | – | – | – | – | – | – | – | – | 27.3% | – |
| Operating income | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Corporate Segment [Member] | $3.19M | – | – | – | – | – | – | – | – | – | – |
| Nano Vibronix [Member] | -$3.24M | -$3.58M | – | – | – | – | – | – | – | – | -9.4% |
| ENvue [Member] | -$16.45M | – | – | – | – | – | – | – | – | – | – |
By product or service
By region
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $2.51M | $2.45M | $2.16M | $710.00M | $1.63M | $467.00K | $331.00K | $164.00K | $90.00K | $89.00K | 98.3% | +2.4% |
| Australia New Zealand [Member] | $20.00K | $41.00K | – | – | – | – | – | – | – | – | 0.8% | -51.2% |
| Other Country [Member] | $15.00K | $50.00K | – | $5.00M | $39.00K | $5.00K | – | – | – | – | 0.6% | -70.0% |
| Europe [Member] | $8.00K | $17.00K | $101.00K | $25.00M | $18.00K | $147.00K | $168.00K | $58.00K | $14.00K | $30.00K | 0.3% | -52.9% |
| Israel | – | $4.00K | $1.00K | – | $5.00K | $3.00K | $14.00K | $49.00K | $8.00K | $13.00K | – | – |
| Other [Member] | – | – | – | – | – | – | – | $30.00K | $39.00K | $51.00K | – | – |
| India | – | – | – | $3.00M | – | $1.00K | $12.00K | $17.00K | $14.00K | $24.00K | – | – |
| United Kingdom | – | – | – | – | – | – | – | $50.00K | $74.00K | $74.00K | – | – |
| Other [Member] | – | – | – | – | – | $5.00K | $5.00K | $30.00K | $39.00K | $51.00K | – | – |
| Australia | – | $29.00K | $19.00K | $9.00M | $6.00K | – | – | – | – | – | – | – |
| New Zealand | – | $12.00K | – | – | – | – | – | – | – | – | – | – |
From the segment and revenue-disaggregation notes of ENvue Medical's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.